By Christina Jewett of The New York Times If you don’t suffer from migraine headaches, you probably know at least one person who does. Nearly 40 million Americans get them 28 million of them women and girls making migraine the second most disabling condition in the world after low back pain. .
NEW YORK, Sept. 01, 2022 Axsome Therapeutics, Inc. , a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system disorders, announced that. | September 1, 2022